Analysis of Drug Resistance and Treatment of Refractory Helicobacter pylori Infection in Patients With Nodular Gastritis
10.3969/j.issn.1008-7125.2021.01.006
- Author:
Yuanyuan NIAN
1
;
Hongyang ZHANG
1
;
Xianmei MENG
1
;
Zhichao XU
1
;
Hongsuo CHEN
1
;
Zhenyu JIANG
1
;
Yong WU
1
;
Jingjie ZHANG
1
Author Information
1. Department of Gastroenterology, the Second Affiliated Hospital of Baotou Medical College
- Publication Type:Journal Article
- Keywords:
Antibiotic Resistance;
CYP2C19;
Helicobacter pylori;
Nodular Gastritis;
Therapy
- From:
Chinese Journal of Gastroenterology
2021;26(1):35-38
- CountryChina
- Language:Chinese
-
Abstract:
Nodular gastritis is directly related to Helicobacter pylori (Hp) infection. Refractory Hp infection has significant impact on the treatment efficacy and prognosis of nodular gastritis. Aims: To analyze the spheroidization and antibiotic resistance of refractory Hp and PPI drug metabolic enzyme CYP2C19 gene polymorphism in patients with nodular gastritis, so as to promote the eradication rate of refractory Hp infection in patients with nodular gastritis. Methods: Refractory Hp infection patients with nodular gastritis from Oct. 2019 to Nov. 2020 at the Second Affiliated Hospital of Baotou Medical College were enrolled. Hp strains were cultured in microaerophilic environment. Immunohistochemistry was used to detect Hp spheroidization. Mutation sites of antibiotic resistance genes and host CYP2C19 gene polymorphism were detected by PCR. According to the results of genetic testing, individualized therapy was given and follow up was performed, the eradication rate of intention-to-treat was calculated. Results: A total of 42 patients with refractory Hp nodular gastritis were enrolled. Among them, lymphocyte accumulation was found in 33.3% patients. Hp spheroidization was found in 2 patients, and the spheroidization rates were 20% and 10%, respectively. There were 25 intensive metabolizer, 15 intermediate metabolizer and 2 poor metabolizer of CYP2C19. Antibiotic resistance gene detection showed that the drug resistance rate of amoxicillin, clarithromycin, levofloxacin, furazolidone, tetracycline, metronidazole were 4.8%, 38.1%, 35.7%, 47.6%, 42.9% and 61.9%, respectively. Twenty-two (52.4%) of the patients developed resistance to 3 or more antibiotics. The total eradication rate of intention-to-treat was 83.3%, of which high-dose dual therapy was 88.9%. Conclusions: Multi-antibiotic resistance and CYP2C19 may be the main reason for the failure of eradication of refractory Hp in nodular gastritis. Hp spheroidization has little effect on the efficacy of eradication therapy. The amoxicillin resistance rate is still significantly lower than that of other antibiotics, and high-dose dual therapy is a better option.
